Clinical Trials 2021
-
s Sponsored
Rethinking data quality best practice in the era of decentralised clinical trials
Pandemic-related disruptions have accelerated much-needed change in clinical operations, but this change has been accompanied by questions about data collection and data quality. In a recent survey commissioned by Oracle Health Sciences, more than 75% of industry respondents indicated that limitations in patients’ ability to attend on-site visits sped up their adoption of decentralised clinical trial...
-
s Sponsored
Does your clinical trial enrolment meet today’s diversity standards?
As the interrelationship of race, socioeconomic status and healthcare outcomes has begun making international headlines, achieving clinical trial diversity has surfaced as a priority in successful trial conduct. The fundamental premise of diversity in clinical trials seems obvious on the surface. If a prospective therapy, diagnostic, vaccine, or medical procedure is meant to be used on everyone suffering with a certain disease, then its safety...
-
Maximising the return on investment in clinical research
Clinical studies are always expensive and time-consuming but only sometimes yield insights that improve health and well-being. Implementing best practices in design, analysis and communication can help researchers get the most out of their hard work. The purpose of clinical research in global health is to generate knowledge that improves and saves lives. However, good...
-
s Sponsored
Increased role for patients helps boost clinical trials
A shift towards decentralised clinical trials is helping gather rapid real-time patient data to help in the development of new drugs and therapies. Patients are playing an increasingly pivotal role in clinical trials as technology facilitates remote and real-time collection of data to support development of new treatments. COVID-19 has accelerated the pace of that change and expedited a shift towards...
-
s Sponsored
Why global clinical trials require more aligned regulation
Demands for global regulatory alignment in the clinical trial space have been brought sharply into focus in recent years, particularly against the backdrop of the COVID-19 pandemic. While regulators have a common responsibility to ensure that clinical trials are executed ethically, effectively and safely, different approaches may exist in different countries. But as clinical trials recruit from...
-
Progressing clinical trials during the COVID-19 pandemic
The pandemic has made everyone reconsider how they conduct clinical research. The use of remote consent, off site monitoring, ePro and other technologies had already started to make an impact in how we assess new therapies. The pandemic has accelerated the uptake of technologies and creative approaches, which has increased the engagement of patients and...
-
Putting patients at the heart of clinical research
The UK stands at an inflection point to accelerate change and strengthen our clinical research capability. In March 2021, the Government set out its vision to create a more efficient, patient-centred, pro-innovation and digitally enabled clinical research environment. The MHRA, working with partners across the UK research ecosystem, is actively supporting this vision, which is...
-
s Sponsored
The pandemic as a catalyst for clinical trial acceleration
Industry experts are predicting major changes to the way clinical trials could be conducted in the future. The clinical trial landscape is in the midst of a fundamental transformation. Underpinning this change is the way data is generated for development of investigational new drugs and therapies, remote monitoring of patients, greater access to patient data and inclusion of broader populations in trials. While COVID-19...
-
Transforming patient recruitment using electronic health records
Centralised electronic health records (EHR) can help clinical trial researchers improve efficiency of participant recruitment. Over 50% of clinical trials fail to achieve their recruitment target which incurs significant cost and delay. Using mass media or sampling from known patient pools, results in high screen failures or misses most eligible patients. There is clearly scope...
-
Delivering a new era of clinical research in the UK
Clinical research is helping us deliver a new generation of breakthrough treatments, with the pharmaceutical industry currently working on thousands of new medicines and vaccines. The UK has always had a global reputation for world-leading medical research and does well in early phase clinical trials. However, we could do more when it comes to later-stage,...
Global Cause